1. The main change of the drug standards in Chinese Pharmacopoeia 2015 edition volume II and the precautions for the implementation
Chinese Pharmaceutical Journal 2015;50(20):1761-1763
Depending on the elaboration work to the national drug standards, the writer gives some comments on how to carry out the monographs in Chinese Pharmacopoeia 2015 edition Volume II. The comments is in the items order of national drug standards. The writer also gives the reasons and considerations for some monograph's revision and elaboration so that the stockholders can understand and carry out the new edition pharmacopoeia quickly and exactly.
2. Introduction to the national drug standards of radiopharmaceutical preparations and the main revision in the Chinese Pharmacopoeia 2015 edition
Chinese Pharmaceutical Journal 2015;50(20):1770-1772
The author summarized the national drug standards of radiopharmaceutical preparations and analyzed the existing problems, and gave a brief introduction about the revision in the Chinese Pharmacopoeia 2015 edition.
3.Discussion on the pharmaceutical development of digital medicine and long-acting injections of aripiprazole
Xiao-Fei SI ; Qian TANG ; Chen-Chen XI ; Dian-Zhuo JIANG
The Chinese Journal of Clinical Pharmacology 2024;40(10):1535-1540
Aripiprazole drug products have been used widely for treatment of schizophrenia.The digital medicine and long-acting injections of aripiprazole have received widespread attention in recent years,which can improve patient compliance to some extent.Based on literature investigation,combined with analysis long-acting injections of aripiprazole in China'Encourage generic drug catalogue(third batch)',the approval cases were summarized,and the pharmaceutical considerations were put forward in terms formulation,manufacturing process and quality control,aimed to provide scientific reference for research and development of such drugs.